Cargando…

Photoactivatable Caged Prodrugs of VEGFR-2 Kinase Inhibitors

In this study, we report on the design, synthesis, photokinetic properties and in vitro evaluation of photoactivatable caged prodrugs for the receptor tyrosine kinase VEGFR-2. Highly potent VEGFR-2 inhibitors 1 and 3 were caged by introduction of a photoremovable protecting group (PPG) to yield the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinchuk, Boris, Horbert, Rebecca, Döbber, Alexander, Kuhl, Lydia, Peifer, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274539/ https://www.ncbi.nlm.nih.gov/pubmed/27136525 http://dx.doi.org/10.3390/molecules21050570

Ejemplares similares

Design, Synthesis, and In Vitro Evaluation of the Photoactivatable Prodrug of the PARP Inhibitor Talazoparib
por: Li, Jiaguo, et al.
Publicado: (2020)

Ligand Evolution in the Photoactivatable Platinum(IV) Anticancer Prodrugs
por: Huang, Jingjing, et al.
Publicado: (2022)

Ultra-bright Photoactivatable Fluorophores Created by Reductive Caging
por: Vaughan, Joshua C., et al.
Publicado: (2012)

Photoactivatable Cell-Selective Dinuclear trans-Diazidoplatinum(IV) Anticancer Prodrugs
por: Shi, Huayun, et al.
Publicado: (2018)

Photoswitchable Azo- and Diazocine-Functionalized Derivatives of the VEGFR-2 Inhibitor Axitinib
por: Heintze, Linda, et al.
Publicado: (2020)

Photoactivatable Fluorescent Dyes with Hydrophilic Caging Groups and Their Use in Multicolor Nanoscopy
por: Butkevich, Alexey N., et al.
Publicado: (2021)

Marine Derived Hamacanthins as Lead for the Development of Novel PDGFRβ Protein Kinase Inhibitors
por: Pinchuk, Boris, et al.
Publicado: (2013)

Bioorthogonal Caging-Group-Free Photoactivatable Probes for Minimal-Linkage-Error Nanoscopy
por: Aktalay, Ayse, et al.
Publicado: (2023)

A general design of caging-group-free photoactivatable fluorophores for live-cell nanoscopy
por: Lincoln, Richard, et al.
Publicado: (2022)

Photoinduced Conversion of Antimelanoma Agent Dabrafenib to a Novel Fluorescent BRAF(V600E) Inhibitor
por: Pinchuk, Boris, et al.
Publicado: (2016)

Synthesis, Characterization and in vitro Studies of a Cathepsin B‐Cleavable Prodrug of the VEGFR Inhibitor Sunitinib
por: Karnthaler‐Benbakka, Claudia, et al.
Publicado: (2018)

Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors
por: Steeghs, Neeltje, et al.
Publicado: (2009)

Photoactivatable drugs for nicotinic optopharmacology
por: Banala, Sambashiva, et al.
Publicado: (2018)

Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models
por: Dev, I K, et al.
Publicado: (2004)

Red Photoactivatable Genetic Optical-Indicators
por: Hussein, Wessal, et al.
Publicado: (2020)

Facile synthesis of photoactivatable adenosine analogs
por: White, Dawanna S., et al.
Publicado: (2022)

Photoactivatable BODIPYs for Live-Cell PALM
por: Zhang, Yang, et al.
Publicado: (2023)

Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent
por: Jiang, Zongru, et al.
Publicado: (2020)

Short Peptides with Uncleavable Peptide Bond Mimetics as Photoactivatable Caspase-3 Inhibitors
por: Van Kersavond, Tim, et al.
Publicado: (2019)

Reactive Oxygen Species (ROS)-Sensitive Prodrugs of the Tyrosine Kinase Inhibitor Crizotinib
por: Bielec, Bjoern, et al.
Publicado: (2020)

Development of Second-Generation VEGFR Tyrosine Kinase Inhibitors: Current Status
por: Bhargava, Pankaj, et al.
Publicado: (2011)

Facile and General Synthesis of Photoactivatable Xanthene Dyes**
por: Wysocki, Laura M, et al.
Publicado: (2011)

Photoactivatable oncolytic adenovirus for optogenetic cancer therapy
por: Hagihara, Yasuko, et al.
Publicado: (2020)

Photoactivatable nanogenerators of reactive species for cancer therapy
por: Zheng, Xiaohua, et al.
Publicado: (2021)

Photoactivatable Heptamethine-Based Carbonic Anhydrase Inhibitors Leading to New Anti-Antibacterial Agents
por: Carradori, Simone, et al.
Publicado: (2023)

MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma
por: Kinget, Lisa, et al.
Publicado: (2021)

Sustainable and highly controlled aryl couplings revealed by systematic assessment of photoactivatable linkers
por: Haensch, Veit G., et al.
Publicado: (2022)

Photopharmacological Applications for Cherenkov Radiation Generated by Clinically Used Radionuclides
por: Krebs, Melanie, et al.
Publicado: (2021)

UV light-induced spatial loss of sialic acid capping using a photoactivatable sialyltransferase inhibitor
por: Moons, Sam J., et al.
Publicado: (2023)

ZD6474 – a novel inhibitor of VEGFR and EGFR tyrosine kinase activity
por: Ryan, A J, et al.
Publicado: (2005)

Encapsulation of Pt(iv) prodrugs within a Pt(ii) cage for drug delivery
por: Zheng, Yao-Rong, et al.
Publicado: (2015)

Synthesis and Molecular Docking of Some Novel 3-Thiazolyl-Coumarins as Inhibitors of VEGFR-2 Kinase
por: Abolibda, Tariq Z., et al.
Publicado: (2023)

A volumetric three-dimensional digital light photoactivatable dye display
por: Patel, Shreya K., et al.
Publicado: (2017)

Single-Cell Chemistry of Photoactivatable Platinum Anticancer Complexes
por: Bolitho, Elizabeth M., et al.
Publicado: (2021)

Photoactivatable Large Stokes Shift Fluorophores for Multicolor Nanoscopy
por: Likhotkin, Ilya, et al.
Publicado: (2023)

Near-infrared photoactivatable control of Ca(2+) signaling and optogenetic immunomodulation
por: He, Lian, et al.
Publicado: (2015)

The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase
por: Pierotti, Catia L., et al.
Publicado: (2023)

Photoactivatable prodrug for simultaneous release of mertansine and CO along with a BODIPY derivative as a luminescent marker in mitochondria: a proof of concept for NIR image-guided cancer therapy
por: Tiwari, Rajeshwari, et al.
Publicado: (2020)

Comparative biochemical kinase activity analysis identifies rivoceranib as a highly selective VEGFR2 inhibitor
por: Jang, Seong, et al.
Publicado: (2023)

Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFR Inhibitors
por: Zhao, Tong T., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_57i3cqt3a8npgfmkop77p9plee